Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Nichi-Iko Pharmaceutical Co Ltd
Cash from Investing Activities
Nichi-Iko Pharmaceutical Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
Cash from Investing Activities
-¥9.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Investing Activities
-¥840.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
-21%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Investing Activities
-¥201.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Investing Activities
-¥190.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-16%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Investing Activities
-¥37.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-11%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Investing Activities
-¥846.4B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-72%
|
CAGR 10-Years
-31%
|
See Also
What is Nichi-Iko Pharmaceutical Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-9.3B
JPY
Based on the financial report for Mar 31, 2022, Nichi-Iko Pharmaceutical Co Ltd's Cash from Investing Activities amounts to -9.3B JPY.
What is Nichi-Iko Pharmaceutical Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
35%
Over the last year, the Cash from Investing Activities growth was 68%. The average annual Cash from Investing Activities growth rates for Nichi-Iko Pharmaceutical Co Ltd have been 28% over the past three years , 35% over the past five years .